Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Anti-Ku-positive patients often have muscle weakness and autophagy plays a key role in their condition.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Pulsed electric field treatment may help the immune system fight liver tumors.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Betulinic acid can help treat hepatitis C by stopping virus replication.

The document describes a way to measure biotin in blood to prevent wrong test results in hormone level testing.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Canakinumab's effect on COVID-19 outcomes is unclear.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Adding a second method to PROTACs could improve cancer treatment.

Biologics for severe asthma have known side effects, but some new risks need more study.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.